Sawgrass Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,116
Closed -$362K 222
2018
Q3
$362K Sell
2,116
-24
-1% -$4.11K 0.02% 180
2018
Q2
$277K Buy
2,140
+136
+7% +$17.6K 0.01% 206
2018
Q1
$206K Sell
2,004
-593
-23% -$61K 0.01% 205
2017
Q4
$222K Sell
2,597
-304
-10% -$26K 0.01% 203
2017
Q3
$246K Buy
+2,901
New +$246K 0.01% 198